The role of common variants of the cholesteryl ester transfer protein gene in left main coronary artery disease

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Kolovou, Genovefa ^a   Vasiliadis, Ioannis ^a   Kolovou, Vana ^a   Karakosta, Agathi ^b   Mavrogeni, Sophie ^a   Papadopoulou, Evaggelia ^a   Papamentzelopoulos, Spiridon ^a   Giannakopoulou, Vasiliki ^a   Marvaki, Apostolia ^a   Degiannis, Dimitrios ^a   Bilianou, Helen ^c  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b THRIASIO GENERAL HOSPITAL   (Greece)

^c TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

Author keywords

atherosclerosis; I405V polymorphism.; Left main coronary artery disease; TaqIB polymorphism

Indexed keywords

APOLIPOPROTEIN A; CHOLESTEROL ESTER TRANSFER PROTEIN; LIPID; CETP PROTEIN, HUMAN;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENE EXPRESSION; GENE FREQUENCY; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; LIPID ANALYSIS; LIPID METABOLISM; MAJOR CLINICAL STUDY; AGED; ALLELE; AMINO ACID SUBSTITUTION; ANGIOCARDIOGRAPHY; BLOOD; CORONARY BLOOD VESSEL; EXON; FEMALE; GENETIC ASSOCIATION; GENETICS; GREECE; INTRON; MALE; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; RADIOGRAPHY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ALLELES; AMINO ACID SUBSTITUTION; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; EXONS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GREECE; HUMANS; INTRONS; LIPIDS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 80052563628     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-156     Document Type: Article

References (39)

1. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. Lloyd-Jones DM, Nam BH, D'Agostino RB Sr, Levy D, Murabito JM, Wang TJ, Wilson PW, O'Donnell CJ, JAMA 2004 291 2204 11 10.1001/jama.291.18.2204 15138242 (Pubitemid 38608169)
2. Genetic susceptibility to death from coronary heart disease in a study of twins. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U, N Engl J Med 1994 330 1041 46 10.1056/NEJM199404143301503 8127331 (Pubitemid 24106561)
3. Family history as an independent risk factor for coronary artery disease. Shea S, Ottman R, Gabrieli C, Stein Z, Nichols A, J Am Coll Cardiol 1984 4 793 801 10.1016/S0735-1097(84)80408-8 6481018 (Pubitemid 14012469)
4. Familial aggregation of coronary heart disease and its relation to known genetic risk factors. Ten Kate LP, Boman H, Daiger SP, Motulsky AG, Am J Cardiol 1982 50 945 53 10.1016/0002-9149(82)90400-3 7137046 (Pubitemid 13232013)
5. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. Murabito JM, Pencina MJ, Nam BH, D'Agostino RB Sr, Wang TJ, Lloyd-Jones D, Wilson PW, O'Donnell CJ, JAMA 2005 294 3117 23 10.1001/jama.294.24.3117 16380592 (Pubitemid 43016803)
6. VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB, JAMA 2001 285 1585 91 10.1001/jama.285.12.1585 11268266 (Pubitemid 32240250)
7. Low serum levels of high-density lipoprotein cholesterol and hypolipidaemic treatment. Kolovou GD, Cokkinos DV, Curr Med Res Opin 2002 18 265 68 10.1185/030079902125000534 12240788 (Pubitemid 35014542)
8. Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy. Ballantyne CM, Herd JA, Ferlic LL, Dunn JK, Farmer JA, Jones PH, Schein JR, Gotto AM Jr, Circulation 1999 99 736 43 9989957 (Pubitemid 29083012)
9. Tangier disease with unusual clinical manifestations. Kolovou GD, Wade DP, Sengupta R, Cokkinos DV, Clin Genet 2003 63 323 24 10.1034/j.1399-0004.2003. 00056.x 12702168 (Pubitemid 36949941)
10. Tangier disease four decades of research: a reflection of the importance of HDL. Kolovou GD, Mikhailidis DP, Anagnostopoulou KK, Daskalopoulou SS, Cokkinos DV, Curr Med Chem 2006 13 771 82 10.2174/092986706776055580 16611066
11. Framingham Heart Study. Comparison of year-of-exam- and age-matched estimates of heritability in the Framingham Heart Study data. Mathias RA, Roy-Gagnon MH, Justice CM, Papanicolaou GJ, Fan YT, Pugh EW, Wilson AF, BMC Genet 1999 4 (Suppl 1):s36
12. Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE Family Study. Pérusse L, Rice T, Després JP, Bergeron J, Province MA, Gagnon J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C, Arterioscler Thromb Vasc Biol 1997 17 3263 69 10.1161/01.ATV.17.11.3263 9409321 (Pubitemid 28016087)
13. Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study. North KE, Howard BV, Welty TK, Best LG, Lee ET, Yeh JL, Fabsitz RR, Roman MJ, MacCluer JW, Am J Epidemiol 2003 157 303 14 10.1093/aje/kwf208 12578801 (Pubitemid 36193933)
14. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, Wahlstrand B, Hedner T, Corella D, Tai ES, Ordovas JM, Berglund G, Vartiainen E, Jousilahti P, Hedblad B, Taskinen MR, Newton-Cheh C, Salomaa V, Peltonen L, Groop L, Altshuler DM, Orho-Melander M, Nat Genet 2008 40 189 97 10.1038/ng.75 18193044 (Pubitemid 351171402)
15. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, et al. Nat Genet 2008 40 129 30 10.1038/ng0208-129 18227868 (Pubitemid 351171408)
16. Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Fischer M, Broeckel U, Holmer S, Baessler A, Hengstenberg C, Mayer B, Erdmann J, Klein G, Riegger G, Jacob HJ, Schunkert H, Circulation 2005 111 855 62 10.1161/01.CIR.0000155611.41961.BB 15710764 (Pubitemid 40279886)
17. Cholesteryl ester transfer protein and atherosclerosis. Inazu A, Koizumi J, Mabuchi H, Curr Opin Lipidol 2005 11 389 96
18. Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. Drayna D, Lawn R, Nucleic Acids Res 1987 15 4698 10.1093/nar/15.11.4698 2884631
19. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Kondo I, Berg K, Drayna D, Lawn R, Clin Genet 1989 35 49 56 2564326 (Pubitemid 19029791)
20. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Gudnason V, Kakko S, Nicaud V, Savolainen MJ, Kesäniemi YA, Tahvanainen E, Humphries S, Eur J Clin Invest 1999 29 116 28 10.1046/j.1365-2362.1999.00412.x 10092998 (Pubitemid 29090250)
21. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. Fumeron F, Betoulle D, Luc G, Behague I, Ricard S, Poirier O, Jemaa R, Evans A, Arveiler D, Marques-Vidal P, Bard JM, Fruchart JC, Ducimetiere P, Apfelbaum M, Cambien F, J Clin Invest 1995 96 1664 71 10.1172/JCI118207 7657837
22. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 499 502 4337382
23. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Freeman DJ, Griffin BA, Holmes AP, Lindsay GM, Gaffney D, Packard CJ, Shepherd J, Arterioscler Thromb 1994 14 336 44 10.1161/01.ATV.14.3.336 7907227
24. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, Lie KI, Kastelein JJ, N Engl J Med 1998 338 86 93 10.1056/NEJM199801083380203 9420339 (Pubitemid 28042271)
25. Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis. Chen SN, Cilingiroglu M, Todd J, Lombardi R, Willerson JT, Gotto AM Jr, Ballantyne CM, Marian AJ, BMC Med Genet 2009 10 111 10.1186/1471-2350-10-111 19878569
26. Cholesteryl ester transfer protein gene polymorphisms and severity of coronary stenosis. Kolovou GD, Anagnostopoulou KK, Karyofillis P, Salpea KD, Yiannakouris N, Zarkalis D, Cokkinos DV, Clin Invest Med 2006 29 14 9 16553359
27. Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. Dandona S, Stewart AF, Chen L, Williams K, So D, O'Brien E, Glover C, Lemay M, Assogba O, Vo L, Wang YQ, Labinaz M, Wells GA, McPherson R, Roberts R, J Am Coll Cardiol 2010 56 479 86 10.1016/j.jacc.2009.10.092 20670758
28. Coronary artery disease in twins. Holmes DR Jr, Kennel AJ, Smith HC, Gordon H, Moore SB, Br Heart J 1981 45 193 97 10.1136/hrt.45.2.193 7193041 (Pubitemid 11184104)
29. Premature coronary artery disease in identical male twins studied by selective coronary arteriography. Kreulen TH, Cohn PF, Gorlin R, Cathet Cardiovasc Diagn 1975 1 91 96 10.1002/ccd.1810010112 1241335
30. Epidemiology and clinical impact of different anatomical phenotypes of the left main coronary artery. Capodanno D, Di Salvo ME, Seminara D, Caggegi A, Barrano G, Tagliareni F, Dipasqua F, Tamburino C, Heart Vessels 2011 26 138 44 10.1007/s00380-010-0037-9 20978894
31. Distribution of coronary atherosclerosis in patients with coronary artery disease. Iwasaki K, Matsumoto T, Aono H, Furukawa H, Nagamachi K, Samukawa M, Heart Vessels 2010 25 14 18 10.1007/s00380-009-1155-0 20091393
32. Development of the cardiac blood vessels in staged human embryos. Hirakow R, Acta Anat (Basel) 1983 115 220 30 10.1159/000145693 (Pubitemid 13188635)
33. Neovascularization of embryonic rat hearts cultured in oculo closely mimics in utero coronary vessel development. Rongish BJ, Torry RJ, Tucker DC, Tomanek RJ, J Vasc Res 1994 31 205 15 10.1159/000159045 7517702 (Pubitemid 24210911)
34. Development of the origin of the coronary arteries, a matter of ingrowth or outgrowth? Bogers AJ, Gittenberger-de Groot AC, Poelmann RE, Péault BM, Huysmans HA, Anat Embryol (Berl) 1989 180 437 41 10.1007/BF00305118 (Pubitemid 19255276)
35. Origin of the proximal coronary artery stems and a review of ventricular vascularization in the chick embryo. Waldo KL, Willner W, Kirby ML, Am J Anat 1990 188 109 20 10.1002/aja.1001880202 2375277 (Pubitemid 20185157)
36. Current diagnosis and management of left main coronary disease. Chikwe J, Kim M, Goldstone AB, Fallahi A, Athanasiou T, Eur J Cardiothorac Sur 2010 38 420 8 10.1016/j.ejcts.2010.03.003
37. Left main coronary artery disease: assessment, diagnosis, and therapy. Bergelson BA, Tommaso CL, Am Heart J 1995 129 350 59 10.1016/0002-8703(95)90018- 7 7832109
38. Left main coronary artery stenosis: state-of-the-art. El-Menyar AA, Al Suwaidi J, Holmes Jr, Curr Probl Cardiol 2007 32 103 93 10.1016/j.cpcardiol. 2006.12.002 17382834 (Pubitemid 46437412)
39. Association of apolipoprotein E genotype with early onset of coronary heart disease in Greek men. Kolovou GD, Anagnostopoulou KK, Mikhailidis DP, Panagiotakos DB, Pilatis ND, Cariolou MA, Yiannakouris N, Degiannis D, Stavridis G, Cokkinos DV, Angiology 2005 56 663 70 10.1177/000331970505600603 16327942 (Pubitemid 41376943)